4231-74-7

Usage

Uses

Used in Pharmaceutical Industry:
1-METHYL-1-(2-PYRIDYL)HYDRAZINE is used as a chemical intermediate for the synthesis of various pharmaceutical compounds, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 1-METHYL-1-(2-PYRIDYL)HYDRAZINE is employed as a precursor in the production of pesticides and other agrochemical products, aiding in the advancement of agricultural solutions.
Used in Material Science:
1-METHYL-1-(2-PYRIDYL)HYDRAZINE is utilized as a component in the development of new materials, playing a role in enhancing material properties and contributing to innovations in material science.
Used in Research Labs:
As a reagent, 1-METHYL-1-(2-PYRIDYL)HYDRAZINE is used in research laboratories for the preparation of various derivatives and compounds, facilitating scientific exploration and discovery.

InChI:InChI=1/C6H9N3/c1-9(7)6-4-2-3-5-8-6/h2-5H,7H2,1H3

Upstream product

• 109-09-1 2-chloropyridine 
• 60-34-4 methylhydrazine 
• 109-04-6 2-bromo-pyridine 
• 22038-72-8 methyldiazene 
• 4930-98-7 pyrid-2-ylhydrazine 
• 74-88-4 methyl iodide 
• 16219-98-0 N-methyl-N-(pyridin-2-yl)nitrous amide 

Downstream Products

• 148319-50-0 1-Methyl-4-phenyl-1-(2-pyridyl)thiosemicarbazide 

Relevant academic research and scientific papers

New artificial biomimetic enzyme analogues based on Iron(II/III) schiff base complexes: An effect of (Benz)imidazole organic moieties on phenoxazinone synthase and DNA recognition

Elucidation of the structure and function of biomolecules provides us knowledge that can be transferred into the generation of new materials and eventually applications in e.g., catalysis or bioassays. The main problems, however, concern the complexity of the natural systems and their limited availability, which necessitates utilization of simple biomimetic analogues that are, to a certain degree, similar in terms of structure and thus behaviour. We have, therefore, devised a small library of six tridentate N-heterocyclic coordinating agents (L1–L6), which, upon complexation, form two groups of artificial, monometallic non-heme iron species. Utilization of iron(III) chloride leads to the formation of the 1:1 (Fe:Ln) ‘open’ complexes, whereas iron(II) trifluoromethanosulfonate allows for the synthesis of 1:2 (M:Ln) ‘closed’ systems. The structural differences between the individual complexes are a result of the information encoded within the metallic centre and the chosen counterion, whereas the organic scaffold influences the observed properties. Indeed, the number and nature of the external hydrogen bond donors coming from the presence of (benz)imidazole moieties in the ligand framework are responsible for the observed biological behaviour in terms of mimicking phenoxazinone synthase activity and interaction with DNA.

Dioxygen Activation by an in situ Reduced CuII Hydrazone Complex

A CuII hydrazone complex has been synthesized that can be reduced in situ in boiling methanol to give the corresponding CuI complex. The latter complex readily activates dioxygen under ambient conditions, as was unambiguously shown by isotopic labeling studies. As a consequence of the dioxygen activation, the thienyl moiety appended to the hydrazone ligand is easily oxidized in β position (C-H→C-O), finally leading to a change in the coordination environment of the central metal ion. All relevant complexes have been structurally characterized by single-crystal X-ray diffraction analyses. The hydrazone ligand applied in this study does not mimic a biologically relevant coordination motif in copper-containing oxygenases. Nonetheless, the reactivity of the CuI complex resembles that found in many oxygenases, indicating that hydrazone ligands may be well-suited for the generation of novel bioinspired oxidation catalysts. A CuII complex of a hydrazone ligand with N,N,S-donor functionality is reported that, after in situ reduction, is able to activate dioxygen, leading to a hydroxylation of the ligand and finally resulting in the formation of a CuII complex of a hydrazone ligand acting as an N,N,O-donor.

Supramolecular Control of the Template-Induced Selective Photodimerization of 4-Methyl-7-O-hexylcoumarin

A symmetric ditopic molecular receptor (3), containing two identical hydrogen-bonding recognition subunits, was designed and synthesized. These subunits are capable of binding substrates with complementary donor and acceptor sites to form a supramolecular complex through hydrogen bonding, Receptor 3 was designed to accept two guest molecules, which are held in close proximity within the supramolecular species. The substrate molecule, 4-methyl-7-O-hexylcoumarin (1c), forms a 2:1 complex with a binding constant of 150M-1 for the second substrate, passing first through a 1:1 complex with an affinity constant of 510M-1. The orientation of two molecules of 1c when bound to the template leads to the selective formation of the trans-syn [2+2] photoproduct 2cB upon irradiation. Other photoproducts typically produced in the absence of the template are suppressed.

Mono and dinuclear iridium(iii) complexes featuring bis-tridentate coordination and Schiff-base bridging ligands: The beneficial effect of a second metal ion on luminescence

The synthesis and photophysical properties of a set of iridium(iii) complexes featuring tridentate N^N^O-coordinating ligands are described, of generic structure [Ir(N^C^N-dpyx)(N^N^O-Ln)]+ (n = 1 to 4) (dpyx = 1,3-dipyridyl-4,6-dimethylbenzene). The proligands HLn are Schiff bases synthesised by condensation of salicylaldehydes with N-methyl-hydrazinopyridines: they are able to coordinate to the Ir(iii) via lateral pyridine-N and phenolate-O- atoms and a central hydrazone-N atom; the four examples differ in the substitution pattern within the phenolate ring. The bis-tridentate coordination is confirmed by X-ray diffraction. The complexes are phosphorescent in solution at ambient temperature, with higher quantum yields and longer lifetimes than those of structurally related bis-cyclometallated complexes with an N^N^C-coordinating ligand. Related proligands H2L5 and H2L6 have been prepared from 4,6-bis(1-methyl-hydrazino)pyrimidine. They feature a central pyrimidine and two N^N^O units. They are shown to bind as ditopic, bis-tridentate ligands with two iridium(iii) ions, leading to unprecedented dinuclear complexes of the form [{Ir(N^C^N)}2(O^N^N-N^N^O-Ln)]2+ (n = 5, 6; N^C^N = dpyx or 1,3-dipyridyl-4,6-difluoro-benzene), with an intramolecular Ir?Ir distance of around 6 ? determined crystallographically. Mononuclear analogues [Ir(N^C^N-dpyx)(N^N^O-HLn)]+ have also been isolated. The dinuclear complexes display a well-defined and unusually intense lowest-energy absorption band in the visible region, around 480 nm. They emit much more efficiently than their mononuclear counterparts, even though the emission wavelengths are comparable. Their superior performance appears to be due to an enhancement in the radiative rate constant, affirming conclusions drawn from recent related studies of dinuclear Ir(iii) and Pt(ii) complexes with ditopic, pyrimidine-based cyclometallating ligands.

A family of readily synthesised phosphorescent platinum(ii) complexes based on tridentate: N^N^O -coordinating Schiff-base ligands

The synthesis and photophysical properties of 22 platinum(ii) complexes featuring N^N^O-coordinating ligands are described. The complexes have the form Pt(N^N^O-Ln)Cl (n = 1 to 20). The tridentate ligands comprise lateral pyridine and phenolate rings, offering the metal N and O coordination respectively, linked via an imine or hydrazone unit that provides a further, central N atom for coordination. The proligands HLn, some of which have previously been reported for the coordination of 1st row transition metal ions in other contexts, are Schiff bases that are readily synthesised by condensation of salicylaldehydes either with 8-aminoquinoline (to generate imine-based ligands HL1-4) or with 2-hydrazinopyridines (to generate hydrazone-based proligands HL5-20). The Pt(ii) complexes are prepared under mild conditions upon treatment of the proligands with simple Pt(ii) salts. Metathesis of the chloride ligand by an acetylide is possible, as exemplified by the preparation of two further complexes of the form Pt(N^N^O-Ln)(-CC-Ar), where Ar = 3,5-bis(trifluoromethyl)phenyl. Nine of the complexes have been characterised in the solid state by X-ray diffraction. The imine-based complexes have intense low-energy absorption bands around 520 nm attributed to charge-transfer transitions. They display deep red phosphorescence in solution at ambient temperature, with λmax in the range 635-735 nm, quantum yields up to 4.6% and lifetimes in the microsecond range. The hydrazone complexes that feature a py-NH-NC-Ar linker display pH-dependent absorption spectra owing to the acidity of the hydrazone NH: these complexes have poor photostability in solution. In contrast, their N-methylated analogues (i.e., py-NMe-NC-Ar) show no evidence of photodecomposition. They are phosphorescent in solution at room temperature in the 600-640 nm region, the emission maximum being influenced by substituents in the phenolate ring. The results show how simply prepared tridentate Schiff base ligands-which offer the metal a combination of 5- and 6-membered chelate rings-can provide access to phosphorescent Pt(ii) complexes that have superior emissive properties to those of terpyridines, for example.

Electronic absorption and emission properties of bishydrazone [2?×?2] metallosupramolecular grid-type architectures

Several ditopic ligands containing two tridentate bishydrazone coordination subunits and their Zn(II) and Cd(II) [2 × 2] grid-type complexes were prepared and their photoluminescent properties studied. A special attention was devoted to the influence of the orientation of the hydrazone group N–N[dbnd]in the core of the ligands and their complexes. Its reversal from [pyridine[dbnd]N–N–pyrimidine] (L1) to [pyridine–N–N[dbnd]pyrimidine] (L2) has a strong impact on the observed absorption and emission behaviour of particular ligands (L1 and L2) as well as of their [2 × 2] grid assemblies. The further lateral functionalization of the ligands led to different emission quantum yields of the resulting grids, while their emission and absorption spectra varied very little. The simplest derivative L1 turned out to have the best performance with, for its Zn(II) complex, relatively high quantum yield 60%.

Nickel-catalyzed direct C-H bond sulfenylation of acylhydrazines

A Ni-catalyzed direct C-H bond sulfenylation of acylhydrazines was developed. The reaction used N-(pyridinyl)hydrazine as the bidentate-directing group, which can be smoothly removed through reductive N-N cleavage. This system can bear various important functional groups, providing an efficient route for the preparation of diverse diaryl sulfides.

The cobalt(II) complex of a new tridentate Schiff-base ligand as a catalyst for hydrosilylation of olefins

Condensation of 1-methyl-2-imidazolecarboxaldehyde with 2-(1-methylhydrazinyl)pyridine results in the synthesis of new, tridentate Schiff-base ligand L, which readily reacts with CoCl2 to form a monometallic [CoLCl2] complex that, upon reduction, functions as active hydrosilylation catalyst. The ligand and the [CoLCl2] catalyst have been characterized spectroscopically (MS, NMR, FTIR) and by single crystal X-ray diffraction techniques. The results of preliminary catalytic experimentation show that the cobalt complex can induce hydrosilylation and dehydrogenative silylation of olefins, depending upon the hydrosilane substrate used.

Coupled nanomechanical motions: Metal-ion-effected, ph-modulated, simultaneous extension/contraction motions of double-domain helical/linear molecular strands

A new class of shape-enforced synthetic polyheterocyclic molecular strands, containing both a helical and a linear domain, has been designed and synthesized. On reaction with Pb(II), under the effect of cation binding to the coordination subunits, the helical section unfolds into a linear shape in the complex and the linear domain folds into a helical ligand wrapped around the bound cations. Such double-domain ligand strands are thus able to undergo a combined unfolding-folding interconversion on binding and release of metal cations. These changes can be modulated through coupling to a competing ligand that reversibly binds and releases metal cations, when respectively unprotonated and protonated, on effecting alternate pH changes. The resulting process thus performs nanomechanical extension/contraction molecular motions of a linear motor type, which is fueled by acid-base neutralization.

HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof, wherein the values and alternative values for the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.